𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation

✍ Scribed by Fred de Clerck; Benoit Xhonneux; Ronny van de Wiele

Publisher
SP Birkhäuser Verlag Basel
Year
1985
Tongue
English
Weight
727 KB
Volume
17
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Naftopidil inhibits 5-hydroxytryptamine-
Naftopidil inhibits 5-hydroxytryptamine-induced platelet aggregation and 5-hydroxytryptamine uptake in platelets of healthy volunteers
✍ R. Kirsten; M. Breidert; K. Nelson; A. Heine; S. Rosenkranz; B. Erdeg; G. Niebch 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 405 KB

Naftopidil exerts its antihypertensive action via al-adrenoceptor blockage and Ca 2+ antagonism in vascular smooth muscle. Since the chemically similar 1 -(1-naphthyl) piperazine is known to be a 5-hydroxytryptamine2 receptor antagonist, the 5-hydroxytryptamine (5-HT) antagonistic properties of naft

β-Endorphin-induced release of 5-hydroxy
β-Endorphin-induced release of 5-hydroxytryptamine from human platelets
✍ Ludger H. Rolf; Günter G. Brune 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 312 KB

Platelets of healthy human subjects were incubated with 5-hydroxytryptamine (5-HT) followed by a second incubation with either beta-endorphin (beta-end) or the combination of beta-end and naloxone. beta-End (300 pg/ml) reduced the levels of 5-HT to 50% of initial values within 15-40 min. After 40-80